News & Analysis on Clinical Trial Services & Contract Research And Development
Quotient Sciences: drug substance manufacturing facility expansion
By Jenni Spinner
- Last updated on
Quotient Sciences has announced a £6.3m ($8.7m USD) investment in expansion of its recently acquired Alnwick, UK manufacturing facility. The funds reportedly will expand the company’s manufacturing capacity and create 80 jobs over the next three years.
Quotient Sciences senior vice president of candidate development services Roger Kilburn said, “Science and agility are at the core of Quotient Sciences, and our team strives to innovate and develop smarter approaches to process R&D for our customers and drive the adoption of continuous processing technologies.”